PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 29, 2025Cancer Research0 citations

Targeting Hyaluronic Acid for Therapeutic Advances in Pancreatic Ductal Adenocarcinoma

Abstract B031: Targeting hyaluronic acid in pancreatic ductal adenocarcinoma uncovers novel therapeutic opportunities

View Full Paper
Ask AI
Bookmark
Share

Authors

PSPian SunSpanish National Cancer Research CentreÁDÁngeles DuránCornell UniversityFVFederico VirgaVIB-KU Leuven Center for Cancer Biology

Discussion

Loading...

Member takes

Overview

Observational analysis reveals that targeting hyaluronic acid alters tumor microenvironment and enhances gemcitabine efficacy in pancreatic ductal adenocarcinoma, suggesting new therapeutic strategies.

Key Points

  • Targeting hyaluronic acid drastically reduced tumor progression in pancreatic ductal adenocarcinoma models.
  • Significant HA depletion improved gemcitabine efficacy, enhancing survival rates in tumor-bearing mice.
  • CRISPR technology was utilized to genetically eliminate HA synthases, leading to effective ablation and reprogramming in the tumor microenvironment.
  • The treatment increased infiltration of CD8+ T cells and modified cancer-associated fibroblast populations, indicating a shift towards a more immune-responsive environment.

Cite This Study

Sun et al. (2025) studied this question.

synapsesocial.com/papers/68da58dcc1728099cfd1138ahttps://doi.org/10.1158/1538-7445.pancreatic25-b031
View Full Paper
Ask AI
Bookmark
Share